Market Research

AI in Oncology Market (Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Ovarian Cancer, and Others; Application: Diagnosis, Treatment Selection, Drug Discovery, and patient Management and Care) - Global Industry Analysis, Size, Share, Growth, T

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 128 Pages Transparency Market Research Pvt. Ltd. April, 2024 TNPR18827815
Best Price Guarantee
Price from $5,795
Length 128 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date April, 2024
SKU TNPR18827815

AI in Oncology Market (Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Ovarian Cancer, and Others; Application: Diagnosis, Treatment Selection, Drug Discovery, and patient Management and Care) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034


AI in Oncology Market – Scope of Report

TMR’s report on the global AI in oncology market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global AI in oncology market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global AI in oncology market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the AI in oncology market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global AI in oncology market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global AI in oncology market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global AI in oncology market.

The report delves into the competitive landscape of the global AI in oncology market. Key players operating in the global AI in oncology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global AI in oncology market profiled in this report.

Key Questions Answered in Global AI in oncology Market Report
  • What is the sales/revenue generated by AI in oncology across all regions during the forecast period?
  • What are the opportunities in the global AI in oncology market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
AI in Oncology Market – Research Objectives and Research Approach

The comprehensive report on the global AI in oncology market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global AI in oncology market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global AI in oncology market.


1. Preface
  1.1. Market Definition and Scope
  1.2. Market Segmentation
  1.3. Key Research Objectives
  1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: AI in Oncology Market
4. Market Overview
  4.1. Introduction
  4.1.1. Product Definition
  4.1.2. Industry Evolution/Developments
  4.2. Overview
  4.3. Market Dynamics
  4.3.1. Drivers
  4.3.2. Restraints
  4.3.3. Opportunities
  4.4. AI in Oncology Market Analysis and Forecast, 2020-2034
5. Key Insights
  5.1. Pipeline Analysis
  5.2. Key Product /Brand Analysis
  5.3. Key Mergers & Acquisitions
  5.4. COVID-19 Pandemic Impact on Industry
6. Global AI in Oncology Market Analysis and Forecast, by Cancer Type
  6.1. Introduction & Definition
  6.2. Key Findings/Developments
  6.3. Market Value Forecast, by Cancer Type, 2020-2034
  6.3.1. Lung Cancer
  6.3.2. Breast Cancer
  6.3.3. Colorectal Cancer
  6.3.4. Ovarian Cancer
  6.3.5. Others
  6.4. Market Attractiveness Analysis, by Cancer Type
7. Global AI in Oncology Market Analysis and Forecast, by Application
  7.1. Introduction & Definition
  7.2. Key Findings/Developments
  7.3. Market Value Forecast, by Application, 2020-2034
  7.3.1. Diagnosis
  7.3.2. Treatment Selection
  7.3.3. Drug Discovery
  7.3.4. Patient Management and Care
  7.4. Market Attractiveness Analysis, by Application
8. Global AI in Oncology Market Analysis and Forecast, by End-user
  8.1. Introduction & Definition
  8.2. Key Findings/Developments
  8.3. Market Value Forecast, by End-user, 2020-2034
  8.3.1. Hospitals & Clinics
  8.3.2. Cancer Hospitals
  8.3.3. Research Institutes
  8.4. Market Attractiveness Analysis, by End-user
9. Global AI in Oncology Market Analysis and Forecast, by Region
  9.1. Introduction
  9.2. Key Findings/Developments
  9.3. Market Value Forecast, by Region, 2020-2034
  9.3.1. North America
  9.3.2. Europe
  9.3.3. Asia Pacific
  9.3.4. Latin America
  9.3.5. Middle East & Africa
  9.4. Market Attractiveness Analysis, by Region
10. North America AI in Oncology Market Analysis and Forecast
  10.1. Introduction
  10.2. Key Findings
  10.3. Market Value Forecast, by Cancer Type, 2020-2034
  10.3.1. Lung Cancer
  10.3.2. Breast Cancer
  10.3.3. Colorectal Cancer
  10.3.4. Ovarian Cancer
  10.3.5. Others
  10.4. Market Value Forecast, by Application, 2020-2034
  10.4.1. Diagnosis
  10.4.2. Treatment Selection
  10.4.3. Drug Discovery
  10.4.4. Patient Management and Care
  10.5. Market Value Forecast, by End-user, 2020-2034
  10.5.1. Hospitals & Clinics
  10.5.2. Cancer Hospitals
  10.5.3. Research Institutes
  10.6. Market Value Forecast, by Country, 2020-2034
  10.6.1. U.S.
  10.6.2. Canada
  10.7. Market Attractiveness Analysis
  10.7.1. By Cancer Type
  10.7.2. By Application
  10.7.3. By End-user
  10.7.4. By Country
11. Europe AI in Oncology Market Analysis and Forecast
  11.1. Introduction
  11.2. Key Findings
  11.3. Market Value Forecast, by Cancer Type, 2020-2034
  11.3.1. Lung Cancer
  11.3.2. Breast Cancer
  11.3.3. Colorectal Cancer
  11.3.4. Ovarian Cancer
  11.3.5. Others
  11.4. Market Value Forecast, by Application, 2020-2034
  11.4.1. Diagnosis
  11.4.2. Treatment Selection
  11.4.3. Drug Discovery
  11.4.4. Patient Management and Care
  11.5. Market Value Forecast, by End-user, 2020-2034
  11.5.1. Hospitals & Clinics
  11.5.2. Cancer Hospitals
  11.5.3. Research Institutes
  11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  11.6.1. Germany
  11.6.2. U.K.
  11.6.3. France
  11.6.4. Italy
  11.6.5. Spain
  11.6.6. Rest of Europe
  11.7. Market Attractiveness Analysis
  11.7.1. By Cancer Type
  11.7.2. By Application
  11.7.3. By End-user
  11.7.4. By Country/Sub-region
12. Asia Pacific AI in Oncology Market Analysis and Forecast
  12.1. Introduction
  12.2. Key Findings
  12.3. Market Value Forecast, by Cancer Type, 2020-2034
  12.3.1. Lung Cancer
  12.3.2. Breast Cancer
  12.3.3. Colorectal Cancer
  12.3.4. Ovarian Cancer
  12.3.5. Others
  12.4. Market Value Forecast, by Application, 2020-2034
  12.4.1. Diagnosis
  12.4.2. Treatment Selection
  12.4.3. Drug Discovery
  12.4.4. Patient Management and Care
  12.5. Market Value Forecast, by End-user, 2020-2034
  12.5.1. Hospitals & Clinics
  12.5.2. Cancer Hospitals
  12.5.3. Research Institutes
  12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  12.6.1. China
  12.6.2. Japan
  12.6.3. India
  12.6.4. Australia & New Zealand
  12.6.5. Rest of Asia Pacific
  12.7. Market Attractiveness Analysis
  12.7.1. By Cancer Type
  12.7.2. By Application
  12.7.3. By End-user
  12.7.4. By Country/Sub-region
13. Latin America AI in Oncology Market Analysis and Forecast
  13.1. Introduction
  13.2. Key Findings
  13.3. Market Value Forecast, by Cancer Type, 2020-2034
  13.3.1. Lung Cancer
  13.3.2. Breast Cancer
  13.3.3. Colorectal Cancer
  13.3.4. Ovarian Cancer
  13.3.5. Others
  13.4. Market Value Forecast, by Application, 2020-2034
  13.4.1. Diagnosis
  13.4.2. Treatment Selection
  13.4.3. Drug Discovery
  13.4.4. Patient Management and Care
  13.5. Market Value Forecast, by End-user, 2020-2034
  13.5.1. Hospitals & Clinics
  13.5.2. Cancer Hospitals
  13.5.3. Research Institutes
  13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  13.6.1. Brazil
  13.6.2. Mexico
  13.6.3. Rest of Latin America
  13.7. Market Attractiveness Analysis
  13.7.1. By Cancer Type
  13.7.2. By Application
  13.7.3. By End-user
  13.7.4. By Country/Sub-region
14. Middle East & Africa AI in Oncology Market Analysis and Forecast
  14.1. Introduction
  14.2. Key Findings
  14.3. Market Value Forecast, by Cancer Type, 2020-2034
  14.3.1. Lung Cancer
  14.3.2. Breast Cancer
  14.3.3. Colorectal Cancer
  14.3.4. Ovarian Cancer
  14.3.5. Others
  14.4. Market Value Forecast, by Application, 2020-2034
  14.4.1. Diagnosis
  14.4.2. Treatment Selection
  14.4.3. Drug Discovery
  14.4.4. Patient Management and Care
  14.5. Market Value Forecast, by End-user, 2020-2034
  14.5.1. Hospitals & Clinics
  14.5.2. Cancer Hospitals
  14.5.3. Research Institutes
  14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  14.6.1. GCC Countries
  14.6.2. South Africa
  14.6.3. Rest of Middle East & Africa
  14.7. Market Attractiveness Analysis
  14.7.1. By Cancer Type
  14.7.2. By Application
  14.7.3. By End-user
  14.7.4. By Country/Sub-region
15. Competition Landscape
  15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  15.2. Market Share Analysis, by Company (2023)
  15.3. Company Profiles
  15.3.1. Paige.AI
  15.3.1.1. Company Overview
  15.3.1.2. Product Portfolio
  15.3.1.3. SWOT Analysis
  15.3.1.4. Financial Overview
  15.3.1.5. Strategic Overview
  15.3.2. Tempus
  15.3.2.1. Company Overview
  15.3.2.2. Product Portfolio
  15.3.2.3. SWOT Analysis
  15.3.2.4. Financial Overview
  15.3.2.5. Strategic Overview
  15.3.3. Ibex Medical Analytics
  15.3.3.1. Company Overview
  15.3.3.2. Product Portfolio
  15.3.3.3. SWOT Analysis
  15.3.3.4. Financial Overview
  15.3.3.5. Strategic Overview
  15.3.4. PathAI
  15.3.4.1. Company Overview
  15.3.4.2. Product Portfolio
  15.3.4.3. SWOT Analysis
  15.3.4.4. Financial Overview
  15.3.4.5. Strategic Overview
  15.3.5. Proscia Inc.
  15.3.5.1. Company Overview
  15.3.5.2. Product Portfolio
  15.3.5.3. SWOT Analysis
  15.3.5.4. Financial Overview
  15.3.5.5. Strategic Overview
  15.3.6. DeepMind
  15.3.6.1. Company Overview
  15.3.6.2. Product Portfolio
  15.3.6.3. SWOT Analysis
  15.3.6.4. Financial Overview
  15.3.6.5. Strategic Overview
  15.3.7. SOPHiA GENETICS
  15.3.7.1. Company Overview
  15.3.7.2. Product Portfolio
  15.3.7.3. SWOT Analysis
  15.3.7.4. Financial Overview
  15.3.7.5. Strategic Overview
  15.3.8. Enlitic
  15.3.8.1. Company Overview
  15.3.8.2. Product Portfolio
  15.3.8.3. SWOT Analysis
  15.3.8.4. Financial Overview
  15.3.8.5. Strategic Overview
  15.3.9. Prognos Health
  15.3.9.1. Company Overview
  15.3.9.2. Product Portfolio
  15.3.9.3. SWOT Analysis
  15.3.9.4. Financial Overview
  15.3.9.5. Strategic Overview
  15.3.10. Inspirata, Inc.
  15.3.10.1. Company Overview
  15.3.10.2. Product Portfolio
  15.3.10.3. SWOT Analysis
  15.3.10.4. Financial Overview
  15.3.10.5. Strategic Overview

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings